Category: CovidienSyndicate content

Exec at MDT explains how COV gained $43B payout | The week in medtech M&A

September 24, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together; Medtronic and Covidien prepare 1st Integration Summit; FTC approves Cerner's $1.3B Siemens health IT buy; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

September 17, 2014 by Brian Johnson

Medtronic, Covidien slide on new U.S. inversion rules

September 23, 2014 by Brad Perriello

New rules on inversion mergers announced yesterday by the U.S. Treasury Dept. send shares of Medtronic and Covidien down as questions swirl about the impact ion their pending $43 billion merger.

Medtronic, Covidien slide on new U.S. inversion rules

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic and Covidien prepare 1st Integration Summit

September 18, 2014 by Arezu Sarvestani

Merging medtech titans Medtronic and Covidien are preparing to host the 1st of 4 Integration Summits, scheduled later this month.

Medtronic and Covidien prepare 1st Integration Summit

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

September 17, 2014 by Brian Johnson

A senior executive at Medtronic, vice president of corporate development Chris Cleary, explains how Covidien played "scrappy" upstart all the way to a $43 billion payout.

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

Neurovascular: Covidien begins enrollment in 2 new trials

September 15, 2014 by Arezu Sarvestani

Covidien begins enrolling patients in clinical trials for its Pipeline embolization system as well as all its endovascular stroke devices.

Covidien begins enrollment for 2 new trials

Covidien (NYSE:COV) announced today that it enrolled the 1st patients in a pair of clinical trials evaluating the company's neurovascular technologies.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Treasury Secretary Lew nears decision on Medtronic's Covidien inversion deal

September 8, 2014 by Arezu Sarvestani

Washington D.C. is preparing to move on efforts to penalize companies that move their headquarters overseas to benefit from lower corporate tax rates.

Treasury Secretary Lew nears decision on Medtronic's Covidien inversion deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien's new agreement takes patient monitoring into homes

September 4, 2014 by Arezu Sarvestani

Covidien penetrates home-based patient monitoring through an agreement licensing its ZephyrLIFE telehealth solutions to Geneia for integration into their @Home platform.

Covidien's new agreement takes patient monitoring into homes

Medtech titan Covidien (NYSE:COV) is breaching new ground in home care with its ZephyrLIFE remote monitoring platform, agreeing to license the technology to healthcare solutions company Geneia.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp